Sanofi pulls Zantac from US, Canada; FDA slams Chinese API manufacturer; DMF guidance update | Radio Compass Blog
Sanofi Strategy Under CEO Paul Hudson: Capital Markets Day Slides
Sanofi pulls out of Zika vaccine collaboration as feds gut its R&D contract | Fierce Pharma
Sanofi stock falls as breast cancer drug amcenestrant development stopped as trial fails | Seeking Alpha
Sanofi Might Pull Down Shutters For Two Vaccine Plants In India
Sanofi CEO Hudson singles out his digital ambitions in big executive shakeup | Fierce Pharma
Sanofi ordered to pull dengue vaccine | Business | Chemistry World
Sanofi Trial Failure Halts Work on Breast Cancer Treatment Amcenestrant
Sanofi raises profit forecast following positive Q2 results - PMLiVE
Sanofi pulls Zantac from U.S. and Canada after carcinogen found | Euronews
Reaction 'excessive' to Sanofi's upcoming litigation: analysts
Sanofi pulls Lyxumia's US filing - PMLiVE
MannKind tanks as Sanofi pulls plug on inhaled insulin deal
Sanofi pulls out of late-phase Daiichi vaccine collaboration | Fierce Biotech
Dupixent sales of €10B? We're on track, Sanofi CEO Hudson says | Fierce Pharma
Sanofi abandoning Auvi-Q after dosage problems led to total recall
Sanofi to pull the plug on mRNA Covid-19 vaccine after rivals' success
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact | Fierce Biotech
Sanofi, Maker of World's Top-Selling Insulin, to Exit Diabetes Research - WSJ
Sanofi pulls heartburn drug Zantac from U.S. shelves - STAT
Sanofi pulls out of Revolution Medicines deal on SHP2 inhibitor RMC-46
